Skip to main content
. Author manuscript; available in PMC: 2024 Mar 26.
Published in final edited form as: J Brain Res. 2021 May 18;4(3):127.

Table 2.

Medication Profile and Symptom Scores of Schizophrenia Patients (SZ)

Antipsychotic Medication1 SZ Within-Group mPFC Correlation p value Between-Group mPFC Correlation p value
Positive Symptoms 15.80 (4.65) 0.12 0.23
Negative Symptoms 15.64 (5.47) 0.67 0.67
Total Symptoms 63.76 12.87) 0.004 0.17
Chlorpromazine (CPZ) Equivalents 321.83 (189.62) 0.10 0.34
Illness Duration 26 (11) 0.34 0.50